A 6506 New York Assembly · 2023 Regular Session

Prohibits the sale of xylazine

Summary

Prohibits the knowing sale of xylazine to persons under the age of 21 and without proof of the intended use for institutional, veterinary, or scientific purposes.

Bill status passed 3 of 5 stages cleared

Introduction

Apr 2023

Committee Review

May 2024

Assembly Passage

May 2024

Senate Passage

Governor

Introduced Apr 12, 2023 Last action May 28, 2024

Floor votes · Assembly May 31, 2023

How they voted

146–0

Passed · 4 other

Total votes 150

May 31, 2023

D Democratic103

100 Yea 3

97% Yea

R Republican47

46 Yea 1

97% Yea

Vote distribution

All Yea All Nay Mixed No data

Full legislative history

Actions timeline

Total actions

24

Key actions

6

Committee

6

Amendments

3

May 28, 2024

Committee

RECOMMITTED TO CONSUMER PROTECTION

upper

May 28, 2024

Lower · Passed

REPASSED ASSEMBLY

lower

May 22, 2024

Lower · Passed

AMENDED ON THIRD READING 6506B

lower

Mar 18, 2024

Committee

REFERRED TO CONSUMER PROTECTION

upper

Mar 18, 2024

Lower · Passed

PASSED ASSEMBLY

lower

May 31, 2023

Committee

REFERRED TO CONSUMER PROTECTION

upper

May 31, 2023

Lower · Passed

PASSED ASSEMBLY

lower

May 23, 2023

Committee

REPORTED REFERRED TO RULES

lower

May 18, 2023

Lower · Passed

PRINT NUMBER 6506A

lower

May 18, 2023

Lower · Passed

AMEND AND RECOMMIT TO CODES

lower

May 16, 2023

Committee

REPORTED REFERRED TO CODES

lower

Apr 12, 2023

Committee

REFERRED TO CONSUMER AFFAIRS AND PROTECTION

lower

1 primary · 31 co-sponsors

Sponsors

Role

Legislator

Party

State

District

DDemocratic/Working Families

Brian Cunningham

Jake Blumencranz

RRepublican/Conservative

Jenifer Rajkumar